Reuters logo
BRIEF-Recipharm Q3 EBITDA down at SEK ‍103​ mln
November 9, 2017 / 6:51 AM / a month ago

BRIEF-Recipharm Q3 EBITDA down at SEK ‍103​ mln

Nov 9 (Reuters) - RECIPHARM AB (PUBL)

* Q3 NET SALES SEK ‍1.20 BILLION VERSUS SEK 1.14 BILLION YEAR AGO

* Q3 EBITDA SEK ‍103​ MILLION VERSUS SEK 144 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below